Categories News Press Releases Archives 2025 June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Mar 18 Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 Weeks Read More Share:| | | Mar 17 Exploring the future of dermatology at AAD 2023 Read More Share:| | | Mar 16 You Speak, We Listen: How Community Voices Drive Our Work in HS Read More Share:| | | Mar 16 UCB to Present Eight Bimekizumab Abstracts at AAD 2023 with Results from Studies in Psoriasis, Psoriatic Arthritis, and Hidradenitis Suppurativa Read More Share:| | | Mar 15 Building a Community of Trust in Epilepsy & Rare Syndromes Read More Share:| | |